Institute of Health Biosciences, The University of Tokushima Graduate School, 1-78 Shomachi, Tokushima 770-8505, Japan.
J Chem Inf Model. 2011 Oct 24;51(10):2706-16. doi: 10.1021/ci2002395. Epub 2011 Sep 13.
We carried out full ab initio fragment molecular orbital (FMO) calculations for complexes comprising human neuraminidase-2 (hNEU2) and sialic acid analogues including anti-influenza drugs zanamivir (Relenza) and oseltamivir (Tamiflu) in order to examine the variation in the observed inhibitory activity toward hNEU2 at the atomic and electronic levels. We recently proposed the LERE (linear expression by representative energy terms)-QSAR (quantitative structure-activity relationship) procedure. LERE-QSAR analysis quantitatively revealed that the complex formation is driven by hydrogen-bonding and electrostatic interaction of hNEU2 with sialic acid analogues. The most potent inhibitory activity, that of zanamivir, is attributable to the strong electrostatic interaction of a positively charged guanidino group in zanamivir with negatively charged amino acid residues in hNEU2. After we confirmed that the variation in the observed inhibitory activity among sialic acid analogues is excellently reproducible with the LERE-QSAR equation, we examined the reason for the remarkable difference between the inhibitory potencies of oseltamivir as to hNEU2 and influenza A virus neuraminidase-1 (N1-NA). Several amino acid residues in close contact with a positively charged amino group in oseltamivir are different between hNEU2 and N1-NA. FMO-IFIE (interfragment interaction energy) analysis showed that the difference in amino acid residues causes a remarkably large difference between the overall interaction energies of oseltamivir with hNEU2 and N1-NA. The current results will be useful for the development of new anti-influenza drugs with high selectivity and without the risk of adverse side effects.
我们对包含人神经氨酸酶-2(hNEU2)和唾液酸类似物的复合物进行了全从头碎片分子轨道(FMO)计算,这些类似物包括抗流感药物扎那米韦(Relenza)和奥司他韦(Tamiflu),以在原子和电子水平上检查对 hNEU2 的观察到的抑制活性的变化。我们最近提出了 LERE(代表性能量项的线性表达)-QSAR(定量构效关系)程序。LERE-QSAR 分析定量揭示了复合物的形成是由 hNEU2 与唾液酸类似物的氢键和静电相互作用驱动的。最有效的抑制活性,即扎那米韦的活性,归因于扎那米韦中带正电荷的胍基与 hNEU2 中带负电荷的氨基酸残基之间的强静电相互作用。在我们确认 LERE-QSAR 方程可以极好地再现观察到的唾液酸类似物之间抑制活性的变化之后,我们检查了奥司他韦对 hNEU2 和流感 A 病毒神经氨酸酶-1(N1-NA)的抑制效力之间的显著差异的原因。与奥司他韦中带正电荷的氨基密切接触的几个氨基酸残基在 hNEU2 和 N1-NA 之间是不同的。FMO-IFIE(片段间相互作用能)分析表明,氨基酸残基的差异导致奥司他韦与 hNEU2 和 N1-NA 的整体相互作用能之间存在显著差异。目前的结果将有助于开发具有高选择性和无不良反应风险的新型抗流感药物。